Circulating levels of β-chemokines in systemic lupus erythematosus

Journal of Rheumatology

Volumn 26, Issue 3, 1999, Pages 568-573

  Kaneko, Hiroshi ^a   Ogasawara, Hitoshi ^a   Naito, Toshio ^a   Akimoto, Hiroaki ^a   Lee, Shouseki ^a   Hishikawa, Takashi ^a   Sekigawa, Iwao ^b   Tokano, Yoshiaki ^a   Takasaki, Yoshinari ^a   Hirose, Shun Ichi ^b   Hashimoto, Hiroshi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

Author keywords

chemokine; Disease activity; Human immunodeficiency virus; Systemic lupus erythematosus

Indexed keywords

BETA CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AUTOANTIBODIES; BETAMETHASONE; CHEMOKINE CCL2; DISEASE PROGRESSION; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; RANTES;

EID: 0033053103     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991;9:617-48.
2. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991;3:165-83.
3. Taub DD, Oppenheim JJ. Review of the chemokine meeting: the Third International Symposium of Chemotactic Cytokines. Cytokine 1993;5:175-9.
4. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994;55:97-179.
5. Taub DD, Oppenheim JJ. Chemokines, inflammation and the immune system. Ther Immunol 1994;1:229-46.
6. Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. Chemokines and T lymphocyte activation: I. ß chemokines costimulate human T lymphocyte activation in vitro. J Immunol 1996;156:2095-103.
7. Murphy WJ, Tian ZG, Asai O. et al. Chemokines and T lymphocyte activation: II. Facilitation of human T cell trafficking in severe combined immunodeficiency mice. J Immunol 1996;156:2104-11.
8. Cocchi F, DeVico AL, Garzino-Demo AG, Arya S, Gallo RC, Lusso P. Identification of RANTES, MIP-1α, and MIP-1ß as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-5.
9. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
10. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
11. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand of LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-5.
12. Endres MJ, Clapham PR, Marsh M, et al. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 1996;87:745-56.
13. Heredia A, Vallejo A, Soriano V. Epstein JS, Hewlett IK. Chemokine receptor and HIV-2. AIDS 1997;11:1198-9.
14. Akahoshi T, Wada C, Endo H, et al. Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Arthritis Rheum 1993;36:762-71.
15. Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts: differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 1993;268:5834-9.
16. Robinson E, Keystone EC, Schall TJ, Gillett N, Fish EN. Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1ß production by synovial T cells. Clin Exp Immunol 1995;101:398-407.
17. Noris M, Bernasconi S, Casiraghi F. et al. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest 1995;23:804-9.
18. Wada T, Yokoyama H, Su SB, et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int 1996;49:761-7.
19. Segawa C, Wada T, Furuichi K, Takazawa K, Yokoyama H, Kobayashi K. Steroid pulse therapy in lupus cystitis. Intern Med 1996;35:155-8.
20. Bolster MB, Ludwicka A, Sutherland S, Strange C, Silver RM. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum 1997;40:743-51.
21. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
22. Bombardier C, Gladmann DD, Urowitz MB, Caron D, Chang CH, The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a Disease Activity Index for lupus patients. Arthritis Rheum 1992;35:630-40.
23. Neoh L-P, Akimoto H. Kaneko H, et al. The production of ß-chemokines induced by HIV-2 envelope glycoprolein. AIDS 1997;11:1062-3.
24. Feltkamp TEW, Kirkwood TBL. Maini RN, Aden LA. The first international standard for antibodies to double stranded DNA. Ann Rheum Dis 1988;47:740-6.
25. John M, Hirst SJ, Jose PJ, et al. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J Immunol 1997;158:1841-7.
26. Yano S, Yanagawa H, Nishikawa Y, Mukaida N, Matsushima K, Sone S. T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages. J Immunol 1996;157:2660-5.
27. O'Hehir RE, Lake RA, Schall TJ, Yssel H, Panagiotopoulou E, Lamb JR. Regulation of cytokine and chemokine transcription in a human TH2 type T-cell clone during the induction phase of anergy. Clin Exp Allergy 1996;26:20-7.
28. Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CC-chemokines MIP-1α. MIP-1ß, and RANTES is associated with a type 1 immune response. J Immunol 1996;157:3598-604.
29. Chensue SW, Warmington KS, Ruth JH, Sanghi PS, Lincoln P, Kunkel SL. Role of monocyte chemoattractant protein-1 in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation. Th cell expression, and IL-12 production. J Immunol 1996;157:4602-8.
30. Linker-Israeli M, Cytokine abnormalities in human lupus. Clin Immunol Immunopathol 1992;63:10-2.
31. Via CS, Handwerger BS. B-cell and T-cell function in systemic lupus erythematosus. Curr Opin Rheumatol 1993;5:570-4.
32. Barcellini W, Rizzardi GP, Borghi MO, et al, In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity. Lupus 1996;5:139-45.
33. Hishikawa T, Tokano Y, Sekigawa I, et al. HLA-DP+ T cells and deficient interleukin-2 production in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1990;55:285-96.
34. Poli G, Biswas P, Delfanti F, et al. Chemokines regulate endogenous HIV replication: enhancement by MCP-1 and suppression by RANTES [abstract]. Proceedings, XI International Conference on AIDS, Vancouver, Canada, July 1996. Wordpower Business Services; TU.A. 392.
35. Bisset LR, Rothen M, Joller-Jemelka HI, Dobs RW, Groh PJ, Opravil M. Change in circulating levels of the chemokines macrophage inflammatory proteins 1α and 1ß, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir. AIDS 1997;11:485-91.
36. Espinoza LR, Aguilar HL, Berman A. Gutierrez F. Vasey FB, Germain BF. Rheumatic manifestations associated with human immunodeficiency virus infection. Arthritis Rheum 1989;32:1615-22.
37. de Clerk LS, Couttenye MM, de Broe ME, Stevents WJ. Acquired immunodeficiency syndrome mimicking Sjögren's syndrome and systemic lupus crythematosus. Arthritis Rheum 1988;31:272-5.
38. Herrmann M, Hagenhofer M, Kalden JR. Retroviruses and systemic lupus erythematosus. Immunol Rev 1996;152:145-56.
39. Tamura N, Sekigawa I, Hashimolo H, Yamamoto N, Kira S. Syncytial cell formation in vivo by type C retroviral particles in the systemic lupus erythematosus lung. Clin Exp Immunol 1997;107:474-9.